[2T07] Biology of Diseases 05

1:28 PM - 1:37 PM JST(4:28 AM - 4:37 AM UTC)

[2T07-03] LRBA is a novel risk factor for MAFLD (Metabolic dysfunction-associated fatty liver disease)

^○Daisuke Oikawa¹, Yoshinori Okina¹, Min Gi², Minh Duc Pham³, Thi Thanh Thuy Le⁴, Hiroko Ikenaga³, Tsutomu Matsubara⁵, Hirotaka Takahashi⁶, Takuro Horii⁷, Izuho Hatada⁷, Tatsuya Sawasaki⁶, Hidetaka Kosako⁸, Norifumi Kawada³, Fuminori Tokunaga¹ (1.Dept. of Med. Biochem., Grad. Sch. of Med., Osaka Metropol. Univ., 2.Dept. of Environ. Risk Aces., Grad. Sch. of Med., Osaka Metropol. Univ., 3.Dept. of Hepatol., Grad. Sch. of Med., Osaka Metropol. Univ., 4.Dept. of Glo. Educ. Med. Sci., Grad. Sch. of Med., Osaka Metropol. Univ., 5.Dept. of Anat. Regen. Biol., Grad. Sch. of Med., Osaka Metropol. Univ., 6.PROS., Ehime. Univ., 7.Lab. of Genome Sci., Inst. for Mol. Cell. Res., Gunma Univ., 8.Inst. of Adv. Med. Sci., Tokushima Univ.)

キーテクノロジー：single cell fixed RNA-seq

Keywords:

LRBA、MAFLD、炎症応答

[e-mail]

Password required to view